{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:12:50Z","timestamp":1790809970177,"version":"4.1.0"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2015,6,4]],"date-time":"2015-06-04T00:00:00Z","timestamp":1433376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"crossref","award":["09\/SRC\/B1794"],"award-info":[{"award-number":["09\/SRC\/B1794"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Mesenchymal stem cells (MSCs) are currently under investigation as tools to preserve cardiac structure and function following acute myocardial infarction (AMI). However, concerns have emerged regarding safety of acute intracoronary (IC) MSC delivery. This study aimed to characterize innate prothrombotic activity of MSC and identify means of its mitigation toward safe and efficacious therapeutic IC MSC delivery post-AMI. Expression of the initiator of the coagulation cascade tissue factor (TF) on MSC was detected and quantified by immunofluorescence, FACS, and immunoblotting. MSC-derived TF antigen was catalytically active and capable of supporting thrombin generation in vitro. Addition of MSCs to whole citrated blood enhanced platelet thrombus deposition on collagen at arterial shear, an effect abolished by heparin coadministration. In a porcine AMI model, IC infusion of 25 \u00d7 106 MSC during reperfusion was associated with a decrease in coronary flow reserve but not when coadministered with an antithrombin agent (heparin). Heparin reduced MSC-associated thrombosis incorporating platelets and VWF within the microvasculature. Heparin-assisted therapeutic MSC delivery also reduced apoptosis in the infarct border zone at 24 hours, significantly improved infarct size, left ventricular (LV) ejection fraction, LV volumes, wall motion, and attenuated histologic evidence of scar formation at 6 weeks post-AMI. Heparin alone or heparin-assisted fibroblast control cell delivery had no such effect. Procoagulant TF activity of therapeutic MSCs is associated with reductions in myocardial perfusion when delivered IC may be successfully managed by heparin coadministration. This study highlights an important mechanistic insight into safety concerns associated with therapeutic IC MSC delivery for AMI. Stem Cells \u00a02015;33:2726\u20132737<\/jats:p>","DOI":"10.1002\/stem.2050","type":"journal-article","created":{"date-parts":[[2015,5,12]],"date-time":"2015-05-12T23:38:18Z","timestamp":1431473898000},"page":"2726-2737","source":"Crossref","is-referenced-by-count":104,"title":["Bone Marrow-Derived Mesenchymal Stem Cells Have Innate Procoagulant Activity and Cause Microvascular Obstruction Following Intracoronary Delivery: Amelioration by Antithrombin Therapy"],"prefix":"10.1093","volume":"33","author":[{"given":"Birgitta M.","family":"Gleeson","sequence":"first","affiliation":[{"name":"Centre for Research in Vascular Biology (CRVB) Biosciences Institute University College Cork, Cork, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Martin","sequence":"additional","affiliation":[{"name":"Centre for Research in Vascular Biology (CRVB) Biosciences Institute University College Cork, Cork, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed T.","family":"Ali","sequence":"additional","affiliation":[{"name":"Centre for Research in Vascular Biology (CRVB) Biosciences Institute University College Cork, Cork, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun H. S.","family":"Kumar","sequence":"additional","affiliation":[{"name":"Centre for Research in Vascular Biology (CRVB) Biosciences Institute University College Cork, Cork, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Gopala-Krishnan","family":"Pillai","sequence":"additional","affiliation":[{"name":"Centre for Research in Vascular Biology (CRVB) Biosciences Institute University College Cork, Cork, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujith P. G.","family":"Kumar","sequence":"additional","affiliation":[{"name":"Centre for Research in Vascular Biology (CRVB) Biosciences Institute University College Cork, Cork, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"O'Sullivan","sequence":"additional","affiliation":[{"name":"Centre for Research in Vascular Biology (CRVB) Biosciences Institute University College Cork, Cork, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Whelan","sequence":"additional","affiliation":[{"name":"Centre for Research in Vascular Biology (CRVB) Biosciences Institute University College Cork, Cork, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Stocca","sequence":"additional","affiliation":[{"name":"Centre for Research in Vascular Biology (CRVB) Biosciences Institute University College Cork, Cork, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wisam","family":"Khider","sequence":"additional","affiliation":[{"name":"Centre for Research in Vascular Biology (CRVB) Biosciences Institute University College Cork, Cork, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank P.","family":"Barry","sequence":"additional","affiliation":[{"name":"Regenerative Medicine Institute (REMEDI) National University of Ireland, Galway, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"O'Brien","sequence":"additional","affiliation":[{"name":"Regenerative Medicine Institute (REMEDI) National University of Ireland, Galway, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noel M.","family":"Caplice","sequence":"additional","affiliation":[{"name":"Centre for Research in Vascular Biology (CRVB) Biosciences Institute University College Cork, Cork, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,6,4]]},"reference":[{"key":"2022011112055980900_stem2050-bib-0001","doi-asserted-by":"crossref","first-page":"11474","DOI":"10.1073\/pnas.0504388102","article-title":"Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction","volume":"102","author":"Amado","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022011112055980900_stem2050-bib-0002","doi-asserted-by":"crossref","first-page":"14022","DOI":"10.1073\/pnas.0903201106","article-title":"Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity","volume":"106","author":"Quevedo","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022011112055980900_stem2050-bib-0003","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.ejcts.2010.03.035","article-title":"Intracardiac allogeneic mesenchymal stem cell transplantation elicits neo-angiogenesis in a fully immunocompetent ischaemic swine model","volume":"38","author":"Poncelet","year":"2010","journal-title":"Eur J Cardiothorac Surg"},{"key":"2022011112055980900_stem2050-bib-0004","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0828-282X(09)70094-7","article-title":"The antiapoptotic effect of mesenchymal stem cell transplantation on ischemic myocardium is enhanced by anoxic preconditioning","volume":"25","author":"He","year":"2009","journal-title":"Can J Cardiol"},{"key":"2022011112055980900_stem2050-bib-0005","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1161\/CIRCRESAHA.110.222703","article-title":"Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation","volume":"107","author":"Hatzistergos","year":"2010","journal-title":"Circ Res"},{"key":"2022011112055980900_stem2050-bib-0006","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nm0405-367","article-title":"Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells","volume":"11","author":"Gnecchi","year":"2005","journal-title":"Nat Med"},{"key":"2022011112055980900_stem2050-bib-0007","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s00395-011-0221-9","article-title":"Mesenchymal stromal cells mediate a switch to alternatively activated monocytes\/macrophages after acute myocardial infarction","volume":"106","author":"Dayan","year":"2011","journal-title":"Basic Res Cardiol"},{"key":"2022011112055980900_stem2050-bib-0008","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1182\/blood-2004-04-1559","article-title":"Human mesenchymal stem cells modulate allogeneic immune cell responses","volume":"105","author":"Aggarwal","year":"2005","journal-title":"Blood"},{"key":"2022011112055980900_stem2050-bib-0009","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1161\/ATVBAHA.112.251579","article-title":"Low levels of circulating CD4+FoxP3+ T cells are associated with an increased risk for development of myocardial infarction but not for stroke","volume":"32","author":"Wigren","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2022011112055980900_stem2050-bib-0010","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1001\/jama.2012.25321","article-title":"Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: The POSEIDON randomized trial","volume":"308","author":"Hare","year":"2012","journal-title":"JAMA"},{"key":"2022011112055980900_stem2050-bib-0011","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1161\/CIRCRESAHA.114.303180","article-title":"Autologous mesenchymal stem cells produce concordant improvements in regional function, tissue perfusion, and fibrotic burden when administered to patients undergoing coronary artery bypass grafting: The Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROMETHEUS) Trial","volume":"114","author":"Karantalis","year":"2014","journal-title":"Circ Res"},{"key":"2022011112055980900_stem2050-bib-0012","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.mvr.2009.02.001","article-title":"Is the intravascular administration of mesenchymal stem cells safe? Mesenchymal stem cells and intravital microscopy","volume":"77","author":"Furlani","year":"2009","journal-title":"Microvasc Res"},{"key":"2022011112055980900_stem2050-bib-0013","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/S0140-6736(04)15695-X","article-title":"Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs","volume":"363","author":"Vulliet","year":"2004","journal-title":"Lancet"},{"key":"2022011112055980900_stem2050-bib-0014","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.bbrc.2012.12.134","article-title":"Tissue factor triggers procoagulation in transplanted mesenchymal stem cells leading to thromboembolism","volume":"431","author":"Tatsumi","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"2022011112055980900_stem2050-bib-0015","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1634\/stemcells.2007-1072","article-title":"Metabolic flexibility permits mesenchymal stem cell survival in an ischemic environment","volume":"26","author":"Mylotte","year":"2008","journal-title":"Stem Cells"},{"key":"2022011112055980900_stem2050-bib-0016","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.hlc.2008.01.006","article-title":"Mesenchymal stem cells: Isolation, characterisation and in vivo fluorescent dye tracking","volume":"17","author":"Weir","year":"2008","journal-title":"Heart Lung Circ"},{"key":"2022011112055980900_stem2050-bib-0017","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.atherosclerosis.2011.01.037","article-title":"Pleiotropic role for monocyte C-fms protein in response to vascular injury: Potential therapeutic target","volume":"216","author":"Metharom","year":"2011","journal-title":"Atherosclerosis"},{"key":"2022011112055980900_stem2050-bib-0018","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1089\/scd.2007.0214","article-title":"Progenitor cell therapy in a porcine acute myocardial infarction model induces cardiac hypertrophy, mediated by paracrine secretion of cardiotrophic factors including TGFbeta1","volume":"17","author":"Doyle","year":"2008","journal-title":"Stem Cells Dev"},{"key":"2022011112055980900_stem2050-bib-0019","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/BF01908144","article-title":"Temporal and spatial development of infarcts in porcine hearts","volume":"79","author":"Klein","year":"1984","journal-title":"Basic Res Cardiol"},{"key":"2022011112055980900_stem2050-bib-0020","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1161\/CIRCINTERVENTIONS.109.872044","article-title":"Impact of a single intracoronary administration of adiponectin on myocardial ischemia\/reperfusion injury in a pig model","volume":"3","author":"Kondo","year":"2010","journal-title":"Circ Cardiovasc Interv"},{"key":"2022011112055980900_stem2050-bib-0021","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1161\/CIRCINTERVENTIONS.110.960765","article-title":"Potent long-term cardioprotective effects of single low-dose insulin-like growth factor-1 treatment postmyocardial infarction","volume":"4","author":"O'Sullivan","year":"2011","journal-title":"Circ Cardiovasc Interv"},{"key":"2022011112055980900_stem2050-bib-0022","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/BF00788278","article-title":"Quantitative assessment of myocardial collagen with picrosirius red staining and circularly polarized light","volume":"89","author":"Whittaker","year":"1994","journal-title":"Basic Res Cardiol"},{"key":"2022011112055980900_stem2050-bib-0023","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0092-8674(00)81607-4","article-title":"Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow","volume":"94","author":"Savage","year":"1998","journal-title":"Cell"},{"key":"2022011112055980900_stem2050-bib-0024","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.cardiores.2006.02.016","article-title":"The effects of mesenchymal stem cells transduced with Akt in a porcine myocardial infarction model","volume":"70","author":"Lim","year":"2006","journal-title":"Cardiovasc Res"},{"key":"2022011112055980900_stem2050-bib-0025","doi-asserted-by":"crossref","first-page":"e42819","DOI":"10.1371\/journal.pone.0042819","article-title":"Bivalirudin in combination with heparin to control mesenchymal cell procoagulant activity","volume":"7","author":"Stephenne","year":"2012","journal-title":"PLoS One"},{"key":"2022011112055980900_stem2050-bib-0026","doi-asserted-by":"crossref","first-page":"6687","DOI":"10.1073\/pnas.85.18.6687","article-title":"Activation of factor VII bound to tissue factor: A key early step in the tissue factor pathway of blood coagulation","volume":"85","author":"Rao","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022011112055980900_stem2050-bib-0027","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0022-3565(24)29348-4","article-title":"Administration of a potent antagonist of protease-activated receptor-1 (PAR-1) attenuates vascular restenosis following balloon angioplasty in rats","volume":"298","author":"Andrade-Gordon","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"2022011112055980900_stem2050-bib-0028","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/eurheartj\/ehi818","article-title":"A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction","volume":"27","author":"Freyman","year":"2006","journal-title":"Eur Heart J"},{"key":"2022011112055980900_stem2050-bib-0029","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1093\/eurheartj\/ehp219","article-title":"Microvascular obstruction is a major determinant of infarct healing and subsequent left ventricular remodelling following primary percutaneous coronary intervention","volume":"30","author":"Orn","year":"2009","journal-title":"Eur Heart J"},{"key":"2022011112055980900_stem2050-bib-0030","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1161\/CIRCULATIONAHA.112.120402","article-title":"Association between coronary vascular dysfunction and cardiac mortality in patients with and without diabetes mellitus","volume":"126","author":"Murthy","year":"2012","journal-title":"Circulation"},{"key":"2022011112055980900_stem2050-bib-0031","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1182\/blood.V99.8.2794","article-title":"Coronary no-reflow is caused by shedding of active tissue factor from dissected atherosclerotic plaque","volume":"99","author":"Bonderman","year":"2002","journal-title":"Blood"},{"key":"2022011112055980900_stem2050-bib-0032","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1161\/CIRCINTERVENTIONS.109.884478","article-title":"Anticoagulant therapy for percutaneous coronary intervention","volume":"3","author":"Rao","year":"2010","journal-title":"Circ Cardiovasc Interven"},{"key":"2022011112055980900_stem2050-bib-0033","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1161\/CIRCRESAHA.112.300730","article-title":"Intracoronary infusion of allogeneic mesenchymal precursor cells directly following experimental acute myocardial infarction reduces infarct size, abrogates adverse remodeling and improves cardiac function","volume":"113","author":"Houtgraaf","year":"2013","journal-title":"Circ Res"},{"key":"2022011112055980900_stem2050-bib-0034","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1161\/CIRCRESAHA.112.265678","article-title":"Heparin disrupts the CXCR4\/SDF-1 axis and impairs the functional capacity of bone marrow-derived mononuclear cells used for cardiovascular repair","volume":"111","author":"Seeger","year":"2012","journal-title":"Circ Res"},{"key":"2022011112055980900_stem2050-bib-0035","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1089\/ten.tea.2008.0405","article-title":"Effects of immobilized glycosaminoglycans on the proliferation and differentiation of mesenchymal stem cells","volume":"15","author":"Uygun","year":"2009","journal-title":"Tissue Eng Part A."},{"key":"2022011112055980900_stem2050-bib-0036","article-title":"Engineered extracellular matrix components do not alter the immunomodulatory properties of mesenchymal stromal cells in vitro","author":"Wehner","year":"2012","journal-title":"J Tissue Eng Regen Med"},{"key":"2022011112055980900_stem2050-bib-0037","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0300-9084(03)00078-6","article-title":"1976\u20131983, a critical period in the history of heparin: The discovery of the antithrombin binding site","volume":"85","author":"Petitou","year":"2003","journal-title":"Biochimie"},{"key":"2022011112055980900_stem2050-bib-0038","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/MBC.0b013e328338dc49","article-title":"Weight-adjusted dalteparin for prevention of vascular thromboembolism in advanced pancreatic cancer patients decreases serum tissue factor and serum-mediated induction of cancer cell invasion","volume":"21","author":"Maraveyas","year":"2010","journal-title":"Blood Coagul Fibrinolysis"},{"key":"2022011112055980900_stem2050-bib-0039","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.bbadis.2011.09.007","article-title":"Low molecular weight heparin downregulates tissue factor expression and activity by modulating growth factor receptor-mediated induction of nuclear factor-kappa B","volume":"1812","author":"Ettelaie","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"2022011112055980900_stem2050-bib-0040","doi-asserted-by":"crossref","DOI":"10.1002\/9780470151808.sc02b06s28","article-title":"Preparation of anti-inflammatory mesenchymal stem\/precursor cells (MSCs) through sphere formation using hanging-drop culture technique","volume":"28","author":"Bartosh","year":"2014","journal-title":"Curr Protoc Stem Cell Biol"},{"key":"2022011112055980900_stem2050-bib-0041","doi-asserted-by":"crossref","first-page":"H256","DOI":"10.1152\/ajpheart.00221.2012","article-title":"Cell-based therapy for prevention and reversal of myocardial remodeling","volume":"303","author":"Karantalis","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2022011112055980900_stem2050-bib-0042","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ahj.2010.11.024","article-title":"Rationale and design of the transendocardial injection of autologous human cells (bone marrow or mesenchymal) in chronic ischemic left ventricular dysfunction and heart failure secondary to myocardial infarction (TAC-HFT) trial: A randomized, double-blind, placebo-controlled study of safety and efficacy","volume":"161","author":"Trachtenberg","year":"2011","journal-title":"Am Heart J"},{"key":"2022011112055980900_stem2050-bib-0043","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/jama.2013.282909","article-title":"Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: The TAC-HFT randomized trial","volume":"311","author":"Heldman","year":"2014","journal-title":"JAMA"}],"container-title":["Stem Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fstem.2050","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fstem.2050","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/stem.2050","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/stem.2050","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/stmcls\/article-pdf\/33\/9\/2726\/42017402\/stmcls_33_9_2726.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/stmcls\/article-pdf\/33\/9\/2726\/42017402\/stmcls_33_9_2726.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T23:23:25Z","timestamp":1748388205000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/stmcls\/article\/33\/9\/2726-2737\/6407389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,4]]},"references-count":43,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2015,6,4]]},"published-print":{"date-parts":[[2015,9,1]]}},"URL":"https:\/\/doi.org\/10.1002\/stem.2050","relation":{},"ISSN":["1066-5099","1549-4918"],"issn-type":[{"value":"1066-5099","type":"print"},{"value":"1549-4918","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2015,9,1]]},"published":{"date-parts":[[2015,6,4]]}}}